Artem

About Artem Andrianov, Ph.D., MBA

Professional in the integration of data-driven Risk-based Quality Management (RBQM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, Health 2.0, DGGF, etc. 18+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RBQM research to new frontiers for CROs, pharma and biotech companies.
Jun 2016

5 Most Recent Healthcare Innovation Trends

By |2020-09-23T10:13:12+02:00June 24, 2016|Blog|0 Comments

If I would summarize innovation in Healthcare, I would say, “We dreamed about flying cars and got 140 characters”. The recent Health 2.0 conference in Barcelona (May 2016) has confirmed my feelings. Innovation in healthcare struggles to persuade all major stakeholders: doctors, insurance companies, researchers, [...]

Jun 2016

Press Release: Synergy and Cyntegrity announce partnership to foster RBM practicality

By |2016-11-16T18:35:32+02:00June 22, 2016|News|0 Comments

21.06.2016. Synergy, Russian fastest Contract Research Organization (CRO) and Cyntegrity, a German technology provider for efficient Risk-based Monitoring (RBM), are pleased to announce a partnership, in order to foster the practicality of RBM. Nowadays, the advantages of RBM compared to the traditional monitoring model are [...]

May 2016

Johann Proeve, Ph.D., strengthens Cyntegrity as CSO

By |2016-11-16T18:35:32+02:00May 24, 2016|News|0 Comments

J. Proeve, Ph.D., an expert with 35+ years of experience as Global Data Management Head at Bayer started this week as Chief Scientific Officer at Cyntegrity. He takes the responsibility of building up a proper Risk-based Monitoring (RBM) strategy for each clinical study and develop further Cyntegrity's core product RBM [...]

May 2016

Data from Global RACT Analysis Reveals Subjectivity

By |2020-09-23T09:43:22+02:00May 11, 2016|Blog|0 Comments

What are the most common risks in clinical trials? What challenges faces TransCelerate RACT? Read the answers in the latest article published on ACT. by Moe Alsumidaie, Beat Widler, PhD, Peter Schiemann, PhD, Artem Andrianov, PhD Do you want to know about @RACT more and start [...]

Apr 2016

How is RBM Adopted? Current Status.

By |2016-11-16T18:35:34+02:00April 10, 2016|Blog|0 Comments

The majority of companies are delaying the RBM adoption. Why? The reason lies now in the nature of innovation adoption. The main hesitations of the pragmatists to apply RBM nowadays are connected with: the general complexity of the approach the perceived risk of audit findings [...]

Apr 2016

Join us at Health 2.0 Conference in Barcelona!

By |2020-09-23T10:14:10+02:00April 5, 2016|News|0 Comments

Dear Friends! Do you wish to witness the ground-shaking and revolutionary inventions in the area of clinical trial management? Innovations that make clinical performance control, fraud detection, data integrity, and risk evaluation easy and effective? Design your own cockpit of a clinical trial together with us and [...]

Apr 2016

Metrics Champion Consortium (MCC) partners with Cyntegrity

By |2016-11-16T18:35:35+02:00April 1, 2016|News|0 Comments

  01.04.2016. Cyntegrity, cloud solution service provider for the efficient Risk-based Monitoring (RBM) of a clinical trial, is pleased to announce its partnership with Metrics Champion Consortium (MCC). MCC is the thought leader in providing metrics for the clinical trials industry offering qualitative and quantitative [...]

Go to Top